478 related articles for article (PubMed ID: 30698148)
1. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
[TBL] [Abstract][Full Text] [Related]
2. The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.
Maurer M; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Nakonechna A; Ortiz de Frutos J; Proctor C; Sussman G; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
Allergy; 2017 Dec; 72(12):2005-2016. PubMed ID: 28543019
[TBL] [Abstract][Full Text] [Related]
3. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.
Weller K; Maurer M; Grattan C; Nakonechna A; Abuzakouk M; Bérard F; Sussman G; Giménez-Arnau AM; Ortiz de Frutos J; Knulst A; Canonica GW; Hollis K; McBride D; Balp MM
Clin Transl Allergy; 2015; 5():29. PubMed ID: 26284152
[TBL] [Abstract][Full Text] [Related]
4. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.
Sussman G; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Hunter S; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Maurer M; Nakonechna A; Ortiz de Frutos J; Reynolds M; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
Allergy; 2018 Aug; 73(8):1724-1734. PubMed ID: 29460968
[TBL] [Abstract][Full Text] [Related]
5. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
6. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.
Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A
Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853
[TBL] [Abstract][Full Text] [Related]
7. Burden of chronic urticaria relative to psoriasis in five European countries.
Balp MM; Khalil S; Tian H; Gabriel S; Vietri J; Zuberbier T
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):282-290. PubMed ID: 28898460
[TBL] [Abstract][Full Text] [Related]
8. The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.
Ye YM; Koh YI; Choi JH; Kim MA; Park JW; Kim TB; Nam YH; Chang YS; Park HS
Korean J Intern Med; 2022 Sep; 37(5):1050-1060. PubMed ID: 36068718
[TBL] [Abstract][Full Text] [Related]
9. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria.
Broder MS; Raimundo K; Antonova E; Chang E
Am J Clin Dermatol; 2015 Aug; 16(4):313-321. PubMed ID: 26055728
[TBL] [Abstract][Full Text] [Related]
10. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
[TBL] [Abstract][Full Text] [Related]
11. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria.
Kanters TA; Thio HB; Hakkaart L
Br J Dermatol; 2018 Sep; 179(3):702-708. PubMed ID: 29476533
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.
Balp MM; Vietri J; Tian H; Isherwood G
Patient; 2015 Dec; 8(6):551-8. PubMed ID: 26476961
[TBL] [Abstract][Full Text] [Related]
14. Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.
Choi WS; Lim ES; Ban GY; Kim JH; Shin YS; Park HS; Ye YM
Korean J Intern Med; 2018 Jan; 33(1):185-192. PubMed ID: 27243229
[TBL] [Abstract][Full Text] [Related]
15. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
16. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
Salman A; Demir G; Bekiroglu N
Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
[TBL] [Abstract][Full Text] [Related]
17. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
Gimenez-Arnau A; Bartra J; Ferrer M; Jauregui I; Borbujo J; Figueras I; Muñoz-Bellido FJ; Pedraz J; Serra-Baldrich E; Tejedor-Alonso MA; Velasco M; Terradas P; Labrador M
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):191-199. PubMed ID: 33349612
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
20. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.
Giordano-Labadie F; Becherel PA; Pralong P; Outtas O; Ruer-Mulard M; Berard F; Greco M; Lacour JP; Debons-Peyroutet M; Pelvet B; Lamirand A; Guillet G
Eur J Dermatol; 2021 Apr; 31(2):217-224. PubMed ID: 34001470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
